Pegylated Interferon Reduces Relapses Following Bepirovirsen Treatment in Participants With Chronic Hepatitis B Virus Infection on Nucleos(t)ide Analogues: End of Study Results From the Phase 2b B-Together Study

Conference Reports for NATAP

AASLD
The Liver Meeting
November Fri, Nov 10, 2023 - Mon, Nov 14, 2023


Pegylated Interferon Reduces Relapses Following Bepirovirsen Treatment in Participants With Chronic Hepatitis B Virus Infection on Nucleos(t)ide Analogues: End of Study Results From the Phase 2b B-Together Study

	AASLD 2023 Nov 10-14